Ledger.Open graph →
SEC Form D · filed July 28, 2022

Auron Therapeutics, Inc

Offering
$48.2M
Sold
$26.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WELLESLEY, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Alon D. Lazarus · Wellesley, MADirectorAnna D. French · Wellesley, MADirectorKatharine Yen · Wellesley, MAExec · DirectorEric D. Shiozaki · Wellesley, MADirectorJames Mackay · Laguna Hills, CADirectorHanxiong Li · Laguna Hills, CADirectorRonald D. Dodson · Dallas, TXExec · DirectorBriggs D. Morrison · Wellesley, MADirectorAlexandra Cantley · Somerville, MADirectorRicardo Bekin · Chicago, ILExec · DirectorMatthew Glick · Brooklyn, NYDirectorWilliam Hapworth · Brooklyn, NYDirectorEric D. Shiozaki · Wellesley, MADirectorBriggs D. Morrison · Wellesley, MADirectorAlexandra Cantley · Somerville, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗